Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer

Genes Chromosomes and Cancer

Volumn 45, Issue 4, 2006, Pages 411-419

  Alarmo, Emma Leena ^a   Rauta, Jenita ^a   Kauraniemi, Päivikki ^a   Karhu, Ritva ^a   Kuukasjärvi, Tuula ^a   Kallioniemi, Anne ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; OSTEOGENIC PROTEIN 1;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DEVELOPMENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VERTEBRATE;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 20; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

VERTEBRATA;

EID: 33644748121     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20307     Document Type: Article

References (39)

1. Albertson DG, Collins C, McCormick F, Gray JW. 2003. Chromosome aberrations in solid tumors. Nat Genet 34:369-376.
2. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146.
3. Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A. 2001. Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 45:83-86.
4. Baade Ro T, Utne Holt R, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, Sundan A, Borset M. 2004. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 23:3024-3032.
5. Botchkarev VA. 2003. Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol 120:36-47.
6. Constam DB, Robertson EJ. 1999. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 144:139-149.
7. Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nor J, McCauley LK, Taichman RS, Keller ET. 2004. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res 64:994-999.
8. Derynck R, Zhang YE. 2003. Smad-dependent and smad-independent pathways in TGF-beta family signalling. Nature 425:577-584.
9. Ducy P, Karsenty G. 2000. The family of bone morphogenetic proteins. Kidney Int 57:2207-2214.
10. Ethier SP. 2003. Identifying and validating causal genetic alterations in human breast cancer. Breast Cancer Res Treat 78:285-287.
11. Franzen A, Heldin NE. 2001. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Biochem Biophys Res Commun 285:773-781.
12. Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL, Kreisberg J. 2000. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta 1497:186-196.
13. Guhaniyogi J, Brewer G. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
14. Hodgson JG, Chin K, Collins C, Gray JW. 2003. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78:337-345.
15. Hogan BL. 1996. Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432-438.
16. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A. 2002. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62:6240-6245.
17. Itoh S, Itoh F, Goumans MJ, Ten Dijke P. 2000. Signaling of transforming growth factor-beta family members through smad proteins. Eur J Biochem 267:6954-6967.
18. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM. 1994. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
19. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D, Gray JW. 1992. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321-5325.
20. Kauraniemi P, Kuukasjarvi T, Sauter G, Kallioniemi A. 2003. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. Am J Pathol 163:1979-1984.
21. Kawabata M, Imamura T, Miyazono K. 1998. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49-61.
22. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. 2001. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 20:333-349.
23. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847.
24. Langenfeld EM, Galvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. 2003. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24:1445-1454.
25. Langenfeld EM, Langenfeld J. 2004. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2:141-149.
26. Masuda H, Fukabori Y, Nakano K, Takezawa Y, CSuzuki T, Yamanaka H. 2003. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate 54:268-274.
27. Miyazono K. 2000. Positive and negative regulation of TGF-beta signaling. J Cell Sci 113:1101-1109.
28. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE, Dale TC. 1996. Regulation of msx-1, msx-2, bmp-2 and bmp-4 during foetal and postnatal mammary gland development. Development 122:2729-2737.
29. Pouliot F, Blais A, Labrie C. 2003. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res 63:277-281.
30. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J. 2003. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63:8861-8868.
31. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. 2005. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65:448-456.
32. Schwalbe M, Sanger J, Eggers R, Naumann A, Schmidt A, Hoffken K, Clement JH. 2003. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int J Oncol 23:89-95.
33. Taipale J, Beachy PA. 2001. The hedgehog and wnt signalling pathways in cancer. Nature 411:349-354.
34. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, Kallioniemi OP. 1996. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56:3441-3445.
35. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP. 1998. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21:177-184.
36. Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino AP, Pelte MF, Schafer P, Kurtz J, Bouchardy C. 2003. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104:778-781.
37. Wang S, Hirschberg R. 2004. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 279:23200-23206.
38. Wang SN, Lapage J, Hirschberg R. 2001. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12:2392-2399.
39. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. 2005. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65:5769-5777.